| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/28/2000 | CA2367002A1 Increasing cerebral bioavailability of drugs |
| 09/28/2000 | CA2366998A1 Quinazoline formulations and therapeutic use thereof |
| 09/28/2000 | CA2366926A1 Pharmaceutical compositions comprising dipeptidy peptidase iv inhibitors for the promotion of growth |
| 09/28/2000 | CA2366908A1 Vaccine composition |
| 09/28/2000 | CA2366869A1 Use of trehalose for stabilising a liquid vaccine |
| 09/28/2000 | CA2366859A1 Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof |
| 09/28/2000 | CA2366845A1 Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained |
| 09/28/2000 | CA2366669A1 Cell-culture and polymer constructs |
| 09/28/2000 | CA2366617A1 Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil |
| 09/28/2000 | CA2366613A1 Particle based vaccine composition |
| 09/27/2000 | EP1038891A2 Water soluble or water dispersable polymeric salts |
| 09/27/2000 | EP1038574A2 Method and apparatus for preparing dispersions containing active substances |
| 09/27/2000 | EP1038540A2 Elongated implant made of a bioresorbable polymer and manufacturing method |
| 09/27/2000 | EP1038530A2 Immunomodulator comprising DNA |
| 09/27/2000 | EP1038528A1 Pentosan polysulfate containing medicament and implant for treating fibrosis |
| 09/27/2000 | EP1038527A1 Process for producing granulates containing riboflavine |
| 09/27/2000 | EP1038521A1 Flexible gelatin free encapsulation material useful for pharmaceuticals, paint balls and other formulations |
| 09/27/2000 | EP1038016A2 Needle-free injection of formulated nucleic acid molecules |
| 09/27/2000 | EP1037938A1 Hyperbranched polymers or dendrimers having a particular group, preparation method and compositions containing same |
| 09/27/2000 | EP1037929A1 Non-aqueous, heterogeneous polymerization process and reaction product obtained thereby |
| 09/27/2000 | EP1037703A1 Extrusion device |
| 09/27/2000 | EP1037687A2 Device for enhancing transdermal agent flux |
| 09/27/2000 | EP1037673A1 Charged lipids and uses for the same |
| 09/27/2000 | EP1037667A1 Pharmaceutical hydrogel formulations, drug delivery devices and methods |
| 09/27/2000 | EP1037666A1 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
| 09/27/2000 | EP1037662A1 Method to enhance an immune response of nucleic acid vaccination |
| 09/27/2000 | EP1037653A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
| 09/27/2000 | EP1037652A1 Pharmaceutical compositions based on dalforpristin and quinupristin and preparation |
| 09/27/2000 | EP1037647A1 Medicinal plant dry extracts |
| 09/27/2000 | EP1037634A1 Novel administration form comprising an acid-labile active compound |
| 09/27/2000 | EP1037622A1 Taurine derivatives usable in the treatment of ophthalmic disorders |
| 09/27/2000 | EP1037621A1 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 09/27/2000 | EP1037620A1 Use of formoterol in medicament for inflammation/allergy in upper airways |
| 09/27/2000 | EP1037619A2 Selected c 10? perfluorinated hydrocarbons for liquid ventilation and artificial blood |
| 09/27/2000 | EP1037615A2 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 09/27/2000 | EP1037614A2 A double capsule for the administration of active principles in multiple therapies |
| 09/27/2000 | EP1037613A1 Method and device for producing pharmaceutical formulations containing an extract |
| 09/27/2000 | EP1037612A1 Pharmaceutical compositions containing micronized bicyclic drugs |
| 09/27/2000 | EP1037611A1 Biodegradable mixed polymeric micelles for gene delivery |
| 09/27/2000 | EP1037610A1 Liposomal camptothecin formulations |
| 09/27/2000 | EP1037609A1 Aqueous insecticidal pour-on formulation |
| 09/27/2000 | EP1037608A1 Acoustically activated localized drug delivery |
| 09/27/2000 | EP1037607A1 Novel suppository form comprising an acid-labile active compound |
| 09/27/2000 | EP1037606A1 Preparation with a prolonged retention time at the site of application |
| 09/27/2000 | EP1037604A1 Pharmaceutical aerosol compositions |
| 09/27/2000 | EP1005351A4 An aqueous metal bicarbonate solution and method of use |
| 09/27/2000 | EP0824363B1 Process for manufacturing polymer products with medicamentous depot effect |
| 09/27/2000 | EP0760653B1 Method of grinding pharmaceutical substances |
| 09/27/2000 | EP0754055B1 Group a streptococcal polysaccharide immunogenic compositions and methods |
| 09/27/2000 | CN2397928Y Analgesic wound-surface plaster |
| 09/27/2000 | CN1268186A i (in vivo) use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes |
| 09/27/2000 | CN1268153A Spherical microparticles containing linear polysaccharides |
| 09/27/2000 | CN1268060A Sustained-release oral preparation |
| 09/27/2000 | CN1268059A Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery |
| 09/27/2000 | CN1268057A Cross-linked polysaccharide drug carrier |
| 09/27/2000 | CN1268056A Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases |
| 09/27/2000 | CN1268055A Pharmaceutical suspension comprising nevirapine hemihydrate |
| 09/27/2000 | CN1268054A Combination therapy comprising amlodipine and a statin compound |
| 09/27/2000 | CN1268052A Therapeutic combinations comprising amlodipin and atorvastatin |
| 09/27/2000 | CN1268051A Clear, injectable formulation of an anesthetic compound |
| 09/27/2000 | CN1268050A Pharmaceutical composition for combination of piperidinoalkanol-decongestant |
| 09/27/2000 | CN1267546A Medicine for rheumatism and its preparation |
| 09/27/2000 | CN1267545A Medicine for injury pain and its preparation |
| 09/27/2000 | CN1267536A Cough-relieving Qinbaohong tablet and preparation |
| 09/27/2000 | CN1267535A Cough-relieving Qinbaohong syrup and its preparation |
| 09/27/2000 | CN1267534A Cough-relieving Qinbaohong granule and its preparation |
| 09/27/2000 | CN1267533A Cough-relieving Qinbaohong mixture and its preparation |
| 09/27/2000 | CN1267520A Shimian'an plaster for insomnia |
| 09/27/2000 | CN1267519A Immune regulator, immune regulator food and immune regulator fodder |
| 09/27/2000 | CN1267518A Notoginseng total saponin capsule and its preparation |
| 09/27/2000 | CN1267516A Adhesive polymer substrate and its application |
| 09/27/2000 | CN1056772C Plaster and agentia with Chinese herb medicines for carsickness |
| 09/27/2000 | CN1056769C Osteopathy capsule and preparing technology |
| 09/27/2000 | CN1056766C Instant electuary with Chinese herb medicines for treating colonitis |
| 09/27/2000 | CN1056764C Medicated plaster for accelerating digestion |
| 09/27/2000 | CN1056760C Drug-giving up abstinence capsule and its preparing method |
| 09/27/2000 | CN1056758C Medicine for treatment of burn, carbuncle and ulcers and its prepn. method |
| 09/27/2000 | CN1056756C Vision recovery capsule |
| 09/27/2000 | CN1056754C Hot compress plaster for curing rheumatism |
| 09/27/2000 | CN1056753C Medicinal instant granules for treating pediatric anorexia |
| 09/27/2000 | CN1056752C Traditional Chinese medicine oral liquid for anti-cancer |
| 09/27/2000 | CN1056751C Zhishiqingjie injecta |
| 09/27/2000 | CN1056749C 液体珍珠软胶囊制配方法 Liquid pearl soft capsule system with methods |
| 09/27/2000 | CN1056746C Freeze-dried emulsion containing active constituent |
| 09/26/2000 | US6124360 Solid compositions suitable for oral administration comprising non hygroscopic salts of L-carnitine and alkanoyl-L-carnitine with 2-aminoethanesulfonic acid |
| 09/26/2000 | US6124358 Pharmaceutical composition containing rhein or diacerhein with improved bioavailability |
| 09/26/2000 | US6124355 Oxybutynin therapy |
| 09/26/2000 | US6124337 Treating male impotence by orally ingesting a mixture comprising a disintegrant to accelerate dissolution a phentolamine vasodilator effective within one hour prior to attempting sexual intercourse |
| 09/26/2000 | US6124322 An aqueous thalidomide solution comprising a pure enantiomer of thalidomide dissolved in an isotonic glucose solution |
| 09/26/2000 | US6124273 Sustained release wound healing agents |
| 09/26/2000 | US6124270 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug |
| 09/26/2000 | US6124268 Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof |
| 09/26/2000 | US6124265 Method of making and cross-linking keratin-based films and sheets |
| 09/26/2000 | US6124261 Non-aqueous polar aprotic peptide formulations |
| 09/26/2000 | US6123965 Methods and compositions for enhancing the bioadhesive properties of polymers |
| 09/26/2000 | US6123964 Wet granulation formulation of a growth hormone secretagogue |
| 09/26/2000 | US6123963 Coating or binder for pharmaceutical preparation comprising a polyurethane consisting of polyol(s), polyetherpolyol(s), a diamine having ionic group, and a polyisocyanate, in given proportions, without further additives; storage stability |
| 09/26/2000 | US6123962 Process for producing stabilized pharmaceutical composition |
| 09/26/2000 | US6123961 Without cardiovascular depressing activity side effect, by administering r(-)-4-diethylamino-2-butynyl cyclohexylphenylglycolate or salt, free of its corresponding s-enantiomer |
| 09/26/2000 | US6123960 For cosmetic and dermatological formulations based on lipid vesicles in the form of stable and homogeneous oil-in-water dispersions; solubilize and stabilize acidic organic active agents; treating wrinkles or comedones caused by acne |